FIGS (FIGS) Aandelenoverzicht
FIGS, Inc. is samen met haar dochteronderneming FIGS Canada, Inc. actief als een direct-to-consumer bedrijf op het gebied van kleding en lifestyle voor de gezondheidszorg in de Verenigde Staten en internationaal. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 1/6 |
| Toekomstige groei | 1/6 |
| Prestaties in het verleden | 5/6 |
| Financiële gezondheid | 6/6 |
| Dividenden | 0/6 |
Beloningen
Risicoanalyse
Geen risico's gedetecteerd voor FIGS uit onze risicocontroles.
FIGS Community Fair Values
Create NarrativeSee what 38 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Top Community Narratives
US$14.39
FV
0.9% ondergewaardeerd intrinsieke korting11.00%
Revenue growth p.a.
1.2k
users have viewed this narrative8users have liked this narrative
6users have commented on this narrative
23users have followed this narrative
FIGS, Inc. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$14.26 |
| 52 Week Hoogtepunt | US$17.48 |
| 52 Week Laag | US$6.13 |
| Bèta | 1.02 |
| 1 maand verandering | 42.03% |
| 3 maanden verandering | 23.89% |
| 1 Jaar Verandering | 127.43% |
| 3 jaar verandering | 100.85% |
| 5 jaar verandering | -66.07% |
| Verandering sinds IPO | -52.50% |
Recent nieuws en updates
Narratiefupdate • Aug 07
FIGS: Future Returns Will Reflect Balanced Execution Strength And External Risk
For FIGS, the updated analyst fair value estimate has moved from $14.00 to $15.00 per share. This reflects recent Street price target revisions around $16.00 to $22.00 that are based on strong quarterly results but tempered by global macro and supply chain risks.Seeking Alpha • Aug 02
FIGS Makes For A Better Fit Now (Rating Upgrade)
Summary FIGS, Inc. is upgraded from ‘sell’ to ‘hold’ as valuation now reflects fair value after a 16% share price decline and continued growth. FIGS delivered 28% YoY revenue growth in Q1 2026, driven by a 12% increase in active customers and higher net revenue per customer. Management guides for 14–16% revenue growth and a 27.7% EBITDA increase in 2026, supported by a strong net cash position of $277 million. While industry headwinds and economic uncertainty persist, FIGS’ diversified channels and international expansion underpin cautious optimism for continued performance. Read the full article on Seeking AlphaRecent updates
Narratiefupdate • Aug 07
FIGS: Future Returns Will Reflect Balanced Execution Strength And External Risk
For FIGS, the updated analyst fair value estimate has moved from $14.00 to $15.00 per share. This reflects recent Street price target revisions around $16.00 to $22.00 that are based on strong quarterly results but tempered by global macro and supply chain risks.Seeking Alpha • Aug 02
FIGS Makes For A Better Fit Now (Rating Upgrade)
Summary FIGS, Inc. is upgraded from ‘sell’ to ‘hold’ as valuation now reflects fair value after a 16% share price decline and continued growth. FIGS delivered 28% YoY revenue growth in Q1 2026, driven by a 12% increase in active customers and higher net revenue per customer. Management guides for 14–16% revenue growth and a 27.7% EBITDA increase in 2026, supported by a strong net cash position of $277 million. While industry headwinds and economic uncertainty persist, FIGS’ diversified channels and international expansion underpin cautious optimism for continued performance. Read the full article on Seeking AlphaNarratiefupdate • Jul 08
FIGS: Higher Profitability Assumptions Will Support Stronger Future Share Performance
The fair value estimate for FIGS has been raised from $6.20 to $14.00. This change reflects analysts' updated assumptions for higher revenue growth, stronger profit margins, and a richer future P/E multiple.
Narratiefupdate • Jun 24
FIGS: Execution And 2026 Outlook Are Expected To Sustain Upside Potential
Analysts raised their price target on FIGS by a few dollars into the low to mid $20s, citing steadier growth and profitability assumptions. These revisions leave the stock trading on a slightly lower implied future P/E multiple, even though fair value estimates remain essentially unchanged.Narratiefupdate • Jun 09
FIGS: International Expansion And 2026 Outlook Are Expected To Sustain Upside Potential
Analysts maintained FIGS' fair value estimate at $22.00, making modest adjustments to underlying assumptions such as a slightly lower discount rate and updated margin and growth inputs. These changes reflect refreshed research that incorporates recent price target increases from firms covering the stock.
Narratiefupdate • May 26
FIGS: International Expansion And Margin Recovery Will Support Future Upside Potential
Analysts have inched their FIGS fair value estimate down from $17.75 to $17.63, reflecting a slightly higher discount rate and lower future P/E assumptions, even as they continue to cite international expansion, product initiatives, and scale potential as key support for higher Street price targets in the stock around $17 to $20. Analyst Commentary Recent Street research on FIGS clusters around price targets in the mid-to-high teens, with several firms lifting targets as they reassess the company’s execution and growth opportunities.Narratiefupdate • May 09
FIGS: International Expansion And Margin Recovery Will Drive Future Upside Potential
FIGS' analyst fair value estimate has been raised from $16.31 to $17.75 as analysts point to higher price targets following Q4 results that exceeded expectations, perceived progress on profitable growth, and ongoing opportunities in areas such as international expansion and product initiatives. Analyst Commentary Recent research on FIGS points to a mix of optimism around growth drivers and discipline on profitability, alongside some caution about margins returning to prior levels.Narratiefupdate • Apr 21
FIGS: International Expansion And Q4 Execution Are Expected To Sustain Upside Potential
Analysts have lifted the FIGS fair value estimate from $20.00 to $22.00, reflecting higher modeled revenue growth, a richer future P/E multiple, and Street research that points to momentum following recent earnings and international expansion commentary. Analyst Commentary Recent Street commentary around FIGS has turned more constructive, with several bullish analysts adjusting their price targets higher and revisiting their views after the latest quarterly update.Narratiefupdate • Apr 07
FIGS: International Expansion And Margin Recovery Efforts Will Drive Upside Potential
Narrative Update on FIGS The updated analyst price target for FIGS reflects a modest recalibration in the model inputs. Recent Street research citing Q4 outperformance, improving profitability and customer trends, and longer term opportunities around international expansion and scaling revenue helps explain why analysts continue to refine their $8 to $20 target range for the stock.Narratiefupdate • Mar 24
FIGS: International Expansion And Margin Recovery Efforts Will Likely Cap Near Term Upside
Narrative Update on FIGS The analyst fair value estimate for FIGS has moved from $9.81 to $16.31 as analysts factor in a series of higher price targets and upgrades that highlight international expansion, margin recovery efforts, and what they describe as sustained recovery and strong momentum following recent Q4 results. Analyst Commentary Recent research on FIGS centers on how the company executes on growth opportunities while working to restore profitability metrics, with price target changes reflecting different views on how quickly that balance can be achieved.Narratiefupdate • Mar 09
FIGS: Q4 Execution And Specialty Retail Tailwinds Are Expected To Drive Upside
The analyst fair value estimate for FIGS has increased to $20.00 from $15.00, as analysts point to Q4 earnings strength, improved profitability assumptions, and confidence that the company’s platform can support higher long term revenue potential. Analyst Commentary Recent research on FIGS has turned more constructive, with several bullish analysts revising their fair value views higher after the latest Q4 print and updated outlook.Narratiefupdate • Feb 23
FIGS: Higher Multiple Assumptions Will Likely Limit Future Share Price Upside
Analysts have nudged their price expectations for FIGS higher, with a modest lift in fair value and future P/E assumptions helping to raise the average price target by about $0.50 as they factor in slightly stronger revenue growth and profit margin potential. Analyst Commentary Recent Street commentary around FIGS points to a mixed but generally constructive stance, with modest price target increases set against ongoing questions about execution and sector risks.Narratiefupdate • Feb 09
FIGS: Demand Uncertainty In Specialty Retail Will Constrain Future Share Performance
Analysts have raised their FIGS fair value estimate from about $4.00 to roughly $6.20 per share. This reflects updated assumptions for revenue growth, profit margins, and the future P/E multiple that are in line with recent price target increases from firms such as Morgan Stanley, Barclays, and Roth Capital.Narratiefupdate • Jan 25
FIGS: Raised Outlook Will Rely On Specialty Retail Tailwinds Into 2026
Narrative Update Analysts have inched up their price targets on FIGS into the high single digit to low double digit US$ range, citing recent research that points to more constructive views on specialty retail through 2026 and firm specific discussions that suggest ongoing business momentum. At the same time, our model keeps fair value steady at US$15.00, with slightly higher revenue growth, margin and future P/E assumptions.Narratiefupdate • Jan 09
FIGS: Upgraded Outlook Hinges On Strong Brand And Healthcare Apparel Demand
Analysts have lifted their FIGS fair value estimate from US$8.00 to US$15.00, reflecting updated assumptions for revenue growth, profit margins and future P/E, along with a series of recent price target increases from Barclays, Roth Capital, Morgan Stanley, Goldman Sachs and BTIG. Analyst Commentary Recent Street research around FIGS has leaned more constructive, with several bullish analysts lifting price targets and initiating positive coverage.Narratiefupdate • Dec 26
FIGS: Reduced Discounting Will Likely Cap Upside Despite Recent Business Momentum
Analysts have modestly lowered our FIGS fair value estimate to approximately $9.17 per share from about $9.53, even as they raise price targets into the mid single to low double digits. They cite stronger than expected post Q3 momentum, improving demand trends, and a richer future earnings multiple outlook, despite slightly softer long term growth and margin assumptions.Narratiefupdate • Dec 12
FIGS: Recent Momentum Will Likely Fade As Reduced Discounting Limits Upside
Our FIGS fair value estimate increases to $9.53 from $8.78 as analysts lift price targets following stronger than expected Q3 results, sustained business momentum signals, and a more constructive view on the brand's long term earnings power. Analyst Commentary Street research on FIGS has turned more constructive overall, with several firms lifting price targets and initiating positive coverage following the company’s strong Q3 performance and improving demand indicators.Narratiefupdate • Nov 27
FIGS: Share Price Will Likely Reflect Limited Upside Amid Market Caution
Analysts have raised their fair value estimate for FIGS from $7.74 to $8.78, citing stronger than expected business momentum, improved revenue growth expectations, and expanding profit margins. Analyst Commentary Recent research coverage of FIGS has provided a mix of constructive insights and measured caution as analysts adjust their expectations.Narratiefupdate • Nov 13
FIGS: Future Competitive Pressures Will Likely Limit Further Upside
FIGS’ analyst price target has increased from $6.74 to $7.74 per share. Analysts point to stronger revenue growth expectations and positive trends within the healthcare apparel sector, which support the revised outlook.Analyse-artikel • Nov 11
There's Reason For Concern Over FIGS, Inc.'s (NYSE:FIGS) Massive 28% Price Jump
The FIGS, Inc. ( NYSE:FIGS ) share price has done very well over the last month, posting an excellent gain of 28%. The...Narratiefupdate • Oct 30
FIGS: High Market Expectations May Limit Upside As Momentum Slows
Analysts have slightly reduced their price target for FIGS, lowering it from $6.74 to $6.74. The adjustment reflects steady business fundamentals and persistent confidence in the brand's strong positioning within the healthcare apparel market.Narratiefupdate • Oct 15
Healthcare, E-Commerce And Global Markets Will Fuel Long-Term Success
Analysts have raised their price target for FIGS from $6.42 to $6.74, citing ongoing strength in U.S. healthcare apparel demand and a solid, debt-free balance sheet as supporting factors for the positive adjustment. Analyst Commentary Recent analyst coverage of FIGS has highlighted both encouraging trends and ongoing areas of caution regarding the company's growth trajectory and valuation.Narratiefupdate • Aug 08
Healthcare, E-Commerce And Global Markets Will Fuel Long-Term Success
The notable upward revision in FIGS' fair value reflects improved consensus revenue growth expectations, more than offsetting the impact of a higher discount rate, resulting in an increased analyst price target from $4.86 to $5.85. What's in the News FIGS, Inc.Analyse-artikel • Jun 30
There's Reason For Concern Over FIGS, Inc.'s (NYSE:FIGS) Massive 35% Price Jump
FIGS, Inc. ( NYSE:FIGS ) shareholders have had their patience rewarded with a 35% share price jump in the last month...Analyse-artikel • May 29
It Looks Like FIGS, Inc.'s (NYSE:FIGS) CEO May Expect Their Salary To Be Put Under The Microscope
Key Insights FIGS to hold its Annual General Meeting on 4th of June CEO Trina Spear's total compensation includes...Analyse-artikel • May 09
Subdued Growth No Barrier To FIGS, Inc. (NYSE:FIGS) With Shares Advancing 40%
Those holding FIGS, Inc. ( NYSE:FIGS ) shares would be relieved that the share price has rebounded 40% in the last...Analyse-artikel • May 03
Is Now The Time To Look At Buying FIGS, Inc. (NYSE:FIGS)?
FIGS, Inc. ( NYSE:FIGS ), might not be a large cap stock, but it led the NYSE gainers with a relatively large price...Seeking Alpha • Apr 24
FIGS, Inc.: Recommending A Hold Despite Tailwinds
Summary FIGS, Inc. is recommended as a “HOLD” due to subpar financial performance and limited upside potential, despite growth plans and strong social media presence. Expansion into untapped markets and new physical stores, particularly in Philadelphia, are key business drivers for FIGS’ future growth. Financial analysis reveals significant declines in EBITDA, net income, and free cash flow, with only a slight increase in net revenue. Tariff risks pose substantial threats to FIGS, potentially increasing production costs and affecting profit margins and demand. Read the full article on Seeking AlphaAnalyse-artikel • Mar 06
FIGS' (NYSE:FIGS) Soft Earnings Don't Show The Whole Picture
The most recent earnings report from FIGS, Inc. ( NYSE:FIGS ) was disappointing for shareholders. While the headline...Seeking Alpha • Mar 06
Figs, Inc. - Slow Growth Is Still Growth
Summary Figs, Inc. is undervalued, as strong private equity interest and a robust balance sheet indicate potential for significant returns. Favorable growth trends in healthcare employment and broader market appeal support optimistic revenue projections for Figs, Inc. Derived equity value suggests a 25% upside from the current share price, highlighting market undervaluation post-IPO. Superior product quality and brand loyalty, coupled with strategic cash reserves, position Figs, Inc. for steady growth and revenue expansion. Read the full article on Seeking AlphaAnalyse-artikel • Jan 30
Be Wary Of FIGS (NYSE:FIGS) And Its Returns On Capital
There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...Seeking Alpha • Dec 12
FIGS: Enter A White Knight?
Summary FIGS, Inc. faces stagnating sales and plummeting earnings, with recent Q3/2024 revenues shrinking by 1.5% YoY and operating losses mounting. Private equity firm Story3 Capital Partners is rumored to have offered $6 a share for FIGS, causing a pre-market rally; investors should take advantage and sell their shares. FIGS' valuation may be attractive to Story3, trading at 1.2x Fwd EV/Sales, compared to 2.4x for Nike and 4.6x for Lululemon. Management's diversification efforts have failed; a focus on international DTC medical scrubs could be a winning strategy under new ownership. Read the full article on Seeking AlphaSeeking Alpha • Nov 13
FIGS Back To Q1 Prices, But The Name Is Still A Hold
Summary Figs reported disappointing 3Q24 results with a 2% revenue decline and a 13 percentage point drop in adjusted EBITDA margins, leading to a 30% stock price drop. The company's high SG&A expenses and lack of growth make it difficult to compete against lower-priced alternatives, justifying my Hold rating. Questionable $25 million investment in a pre-product healthcare education app raises concerns about capital allocation and potential conflicts of interest. Despite a great product, Figs' lack of expense control and high valuation make it an unattractive investment at current prices. Read the full article on Seeking AlphaAnalyse-artikel • Nov 10
The Price Is Right For FIGS, Inc. (NYSE:FIGS) Even After Diving 26%
FIGS, Inc. ( NYSE:FIGS ) shares have had a horrible month, losing 26% after a relatively good period beforehand. The...Analyse-artikel • Oct 18
FIGS (NYSE:FIGS) May Have Issues Allocating Its Capital
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...Rendement voor aandeelhouders
| FIGS | US Luxury | US Markt | |
|---|---|---|---|
| 7D | 31.1% | 0.5% | 2.7% |
| 1Y | 127.4% | -10.7% | 20.9% |
Rendement versus industrie: FIGS overtrof de US Luxury industrie, die het afgelopen jaar een rendement -10.7 % opleverde.
Rendement versus markt: FIGS overtrof de US markt, die het afgelopen jaar een rendement opleverde van 20.9 %.
Prijsvolatiliteit
| FIGS volatility | |
|---|---|
| FIGS Average Weekly Movement | 10.7% |
| Luxury Industry Average Movement | 7.0% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: FIGS heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend vergeleken met de US markt.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 11% ) van FIGS is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2013 | 359 | Trina Spear | www.wearfigs.com |
FIGS, Inc. is, samen met haar dochteronderneming FIGS Canada, Inc., actief als direct-to-consumer bedrijf op het gebied van kleding en lifestyle voor de gezondheidszorg in de Verenigde Staten en internationaal. Het bedrijf ontwerpt en verkoopt scrubkleding en niet-scrubkleding, zoals bovenkleding, onderkleding, schoeisel, compressiesokken, laboratoriumjassen, loungekleding en andere kleding. Het bedrijf biedt ook sportkleding, performance leggings en topjes, superzachte topjes van pima katoen, vesten, fleeces en jassen; en benodigdheden zoals scrubpetten, lanyards, badgehaspels, tassen, baseballpetten en beanies.
FIGS, Inc. Samenvatting
| FIGS fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$2.37b |
| Inkomsten(TTM) | US$61.92m |
| Inkomsten(TTM) | US$710.08m |
38.3x
Koers/Winstverhouding3.3x
P/S-verhoudingIs FIGS overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| FIGS resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$710.08m |
| Kosten van inkomsten | US$220.79m |
| Brutowinst | US$489.29m |
| Overige uitgaven | US$427.37m |
| Inkomsten | US$61.92m |
Laatst gerapporteerde inkomsten
Jun 30, 2026
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 0.37 |
| Brutomarge | 68.91% |
| Nettowinstmarge | 8.72% |
| Schuld/Eigen Vermogen Verhouding | 0% |
Hoe presteerde FIGS op de lange termijn?
Bekijk historische prestaties en vergelijkingBedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/08/10 20:17 |
| Aandelenkoers aan het einde van de dag | 2026/08/07 00:00 |
| Inkomsten | 2026/06/30 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
FIGS, Inc. wordt gevolgd door 14 analisten. 8 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Adrienne Yih-Tennant | Barclays |
| Robert Drbul | BTIG |
| Brooke Roach | Goldman Sachs |